1270B |
Clonazepam and Metabolite, Blood |
1958B |
Estazolam, Blood |
1968B |
Eszopiclone / Zopiclone, Blood |
2120B |
Flurazepam and Metabolites, Blood |
2479B |
Ketamine and Metabolite, Blood |
2483B |
Zolpidem, Blood |
2604B |
Melatonin, Blood |
3057B |
Midazolam, Blood |
3175B |
Nitrazepam and Metabolite, Blood |
4086B |
Ramelteon and Metabolite, Blood |
4236B |
Suvorexant, Blood |
4323B |
Temazepam and Metabolite, Blood |
4543B |
Triazolam and Metabolite, Blood |
4815B |
Xylazine, Blood |
4835B |
Zaleplon, Blood |
8103B |
Environmental Exposure Screen, Blood |
8104B |
Postmortem, Fire Death Screen, Blood (Forensic) |
9139B |
Clonazepam and Metabolite Screen, Blood |
9145UC |
Comprehensive Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |
9188B |
Ketamine and Metabolite Screen, Blood |
9215B |
Nitrazepam and Metabolite Screen, Blood |
9329B |
Benzodiazepines Panel, Blood |
9341B |
Flunitrazepam and Metabolites Screen, Blood |
9352UC |
Expanded Drug Screen, Umbilical Cord Tissue Overview: Detection of in utero exposure to drugs of abuse consistent with maternal use during the second and third trimesters of pregnancy; Newborn (neonatal) toxicology |